Abuse-Deterrent Drug Formulations
Collegium Pharmaceutical, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,771,707 | Abuse-Deterrent Drug Formulations In force · High confidence UsedRemaining | Collegium Pharmaceutical, Inc. | In force | High confidence | ||
| US 8,840,928 | Tamper-Resistant Pharmaceutical Compositions of Opiods and Other Drugs Term ended · USPTO later recorded non-payment Oct 26, 2026 Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended USPTO later recorded non-payment Oct 26, 2026 | Term ended Jul 7, 2023 | High confidence | |
| US 9,044,398 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended | Term ended Jul 7, 2023 | High confidence | |
| US 9,248,195 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended · USPTO later recorded non-payment Mar 11, 2024 Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended USPTO later recorded non-payment Mar 11, 2024 | Term ended Jul 7, 2023 | High confidence | |
| US 9,592,200 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended · USPTO later recorded non-payment Apr 21, 2025 Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended USPTO later recorded non-payment Apr 21, 2025 | Term ended Jul 7, 2023 | High confidence | |
| US 9,682,075 | Tamper-Resistant Pharmaceutical Compositions of Opioids and Other Drugs Term ended Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended | Term ended Jul 7, 2023 | High confidence | |
| US 9,763,883 | Abuse-Deterrent Drug Formulations Term ended Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended | Term ended Jul 7, 2023 | High confidence | |
| US 10,004,729 | Tamper-Resistant Pharmaceutical Compositions of Opioids and Other Drugs Term ended Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended | Term ended Jul 7, 2023 | High confidence | |
| US 10,525,052 | Abuse-Deterrent Drug Formulations Term ended Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended | Term ended Jul 7, 2023 | High confidence | |
| US 10,525,053 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended · USPTO later recorded non-payment Feb 12, 2024 Term ended Jul 7, 2023 · High confidence | Collegium Pharmaceutical, Inc. | Term ended USPTO later recorded non-payment Feb 12, 2024 | Term ended Jul 7, 2023 | High confidence | |
| 21 more records in this group · Pro | ||||||
10 of 31 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 31, including 14 expired.
1 of these is in force and held by Collegium Pharmaceutical, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.